• DOI:10.1002/lt.20492
Corpus ID: 19746065

Management of the hepatitis B virus in the liver transplantation setting: A European and an American perspective

@article{Terrault2005ManagementOT,
  title={Management of the hepatitis B virus in the liver transplantation setting: A European and an American perspective},
  author={N. Terrault and B. Roche and D. Samuel},
  journal={Liver Transplantation},
  year={2005},
  volume={11}
}

N. Terrault, B. Roche, D. Samuel

Published 2005

Medicine

Liver Transplantation

Introduction A total of 5 to 10% of patients undergoing orthotopic liver transplantation (OLT) have hepatitis B virus (HBV)–associated chronic or fulminant liver disease. Long-term survival depends on the prevention of allograft reinfection or the slowing of disease progression in those who have recurrent disease. In the absence of prophylactic measures, the risk of HBV reinfection after OLT is approximately 80% and is related largely to the level of HBV replication at time of transplantation.1… CONTINUE READING

View on Wiley

aasldpubs.onlinelibrary.wiley.com

Save to Library

Create Alert

Cite

Launch Research Feed